Nev. Admin. Code § 453B.110 - Restrictions on donated cancer drugs
1. In addition to the requirements of NRS 453B.080, a donated prescription drug:
(a) Must not be a controlled substance.
(b) Must not be a compounded drug product.
(c) Must not be dispensed by a pharmacist if the pharmacist suspects that the prescription drug is adulterated or misbranded.
(d) Must not be dispensed by a pharmacist if, in the professional judgment of the pharmacist, there is a reasonable concern relating to the safety or efficacy of the prescription drug.
(e) Must not require refrigeration or freezing or other temperature requirements that are not a controlled room temperature.
(f) Must not be a prescription drug for which a program of restrictive distribution has been established by the manufacturer of the prescription drug.
(g) Must not be a prescription drug for which an ongoing clinical trial or study is being conducted.
(h) Must be a prescription drug that was originally dispensed pursuant to a prescription by a pharmacy licensed pursuant to chapter 639 of NRS.
2. As used in this section, "program of restrictive distribution" means a program that is developed in collaboration with the United States Food and Drug Administration by a manufacturer of a drug to reduce the risks associated with that drug by limiting the persons who can prescribe the drug and who can receive the drug.
Notes
NRS 453B.080 and 453B.120
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.